Cure My Disease

Don't miss your cure!

 Log in / Sign up

Student pharmacists may hold the key to better diabetes control in older asian adults

NCT ID NCT06861491

Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This study tests whether student pharmacists can help older Asian adults (age 50+) with uncontrolled type 2 diabetes improve their blood sugar through lifestyle coaching, education, and adherence support. Participants will receive non-pharmacological guidance from student pharmacists, and researchers will track changes in A1C levels and diabetes management understanding. The goal is to see if expanding the role of student pharmacists can lead to better diabetes control in this community.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a behavioral program of lifestyle coaching, diabetes education, and adherence support delivered by student pharmacists
What this could lead to
If it works, this could point toward a low-cost, scalable way to improve diabetes control in older Asian adults using student pharmacists.
What could go wrong
This is a small, early-stage study without a control group, so results may not be generalizable. The intervention is non-pharmacological and may not produce large blood sugar changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

Apr 2025

An estimate. Start dates often move.

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults ≥ 50 years old * Asian or Asian-descent * Diagnosed with T2DM * A1C \>7.0% (uncontrolled) * Take blood glucose measurements as prescribed by their physician, or consistently (defined as missing no more than 1 reading from their regular routine). Exclusion Criteria: * Age \< 50 years old * Not diagnosed with type 2 diabetes, or have diagnoses such as type 1 diabetes, gestational diabetes, or medication induced diabetes * Patients that are on medications that affect glycemic control * Corticosteroids * First-generation antipsychotics (e.g. chlorpromazine, perphenazine, phenothiazines) * Immunosuppressants (e.g. tacrolimus, cyclosporine) * Experiencing acute disease states * Recent surgery/hospitalized within the last 3 months * Active infections * Non-adherence to blood glucose monitoring (defined as missing \> 1 reading from their regular routine or not taking readings as prescribed by their doctor) * Patients with late stage T2DM requiring insulin therapy * Diagnosed with cancer, end-stage renal disease, end-stage liver disease * Received any organ transplant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes mellitus (T2DM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes mellitus (T2DM)

More trials for these conditions

Other studies related to the condition(s) this trial covers.